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Objective: To determine whether 15 multiresistant fseudomonas aeruginosa isolates from an intensive care unit (ICU) 
outbreak were related, were endemic, and belonged to  the 0:12 European clone. 
Methods: Forty-six F! aeruginosa isolates from a large hospital were investigated with respect t o  their antibiotic 
resistance profiles, serogroups, bacteriocin types and DNA fingerprints obtained by pulsed-field gel electrophoresis 
IPFGE) of genomic DNA digested with Xbal. 
Results: Fourteen of the ICU outbreak isolates were indeed identical with respect t o  their serogroup, 0:11, pyocin type, 
10/a, and PFGE type, A. Clone A was endemic and dominant throughout the hospital, even though, within the ICU, it 
underwent phenotypic alterations, such as loss of cell wall lipopolysaccharide side-chains, or acquisition of ceftazidime 
and irnipenem resistance. Bacteriocin typing was more discriminatory than serotyping, but PFGE could differentiate 
further among phenotypically identical strains. It also allowed the tracking of an 0:6 strain, as it was becoming gradually 
more resistant and undergoing a bacteriocin-type conversion while remaining genotypically unaltered. 
Conclusions: Using three typing methods, a nosocomial multiresistant strain distinct from the previously described 
dominant European 0:12 clone was characterized, and the ability of PFGE to  identify clonal isolates even when these 
appear phenotypically distinct was demonstrated. 
Key words: fseudomonas aeruginosa, nosocomial infection, antibiotic resistance, serotyping, bacteriocin typing, 
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Pseudomonas aeruginosa is a predominant nosocomial 
pathogen, ranking among the first three most frequently 
isolated in intensive care units (ICUs) [l]. It  also causes 
life-threatening infections in other circumstances where 
patients are immunocompromised [1,2] or have a 
serious underlying condition, such as cystic fibrosis [3]. 
The infectious pathogen can be transmitted horizon- 
tally within a family [4] or a group of patients [5,6], 
or derive from a common environmental source [7]. 
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Nosocomial strains are frequently multiresistant, and 
are notorious for their ability to acquire further 
resistance mechanisms during antibiotic treatment [8 ] .  
Therefore, surveillance, prevention of infection and 
control of l? aevuginosa are of the utmost importance 
in the hospital environment. The efficiency of such 
measures depends on the availability of appropriate 
epidemiologic studies. To this end, several typing systenis 
for discrimination among strains have been used. Pheno- 
typic methods, such as antibiotic resistance profiles, 
serotyping and bacteriocin typing are useful but are 
often hampered by poor reproducibility and by the 
frequency of phenotypic conversion 191. O n  the other 
hand, genotypic methods (DNA fingerprinting), such 
as hybridization of genomic DNA digested with a 
frequent-cutting restriction endonuclease, with an 
rDNA [lo] or an exotoxin A gene probe [ll], pulsed- 
field gel electrophoresis (PFGE) of genomic DNA 
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digested with a rare-cutting enzyme [12,13], or the 
random amplification of polymorphic DNA sequences 
(RAPD) by the polymerase chain reaction [14-161, are 
highly reproducible and discriminatory [17]. 
We have stuhed isolates from an ICU outbreak, 
together with unrelated isolates from the same hospital, 
by antibiotic resistance profile, serotyping, bacteriocin 
typing and PFGE, admitted to be the most discrimina- 
tory DNA fingerprinting method for this organism 
[18]. We report the comparative results of the four 
methods, which revealed a multiresistant 0:ll strain, 
distinct from the 0: 12 multiresistant clone previously 
reported to be dominant in Greece [19] and the rest of 
Europe [20]. 
MATERIALS AND METHODS 
Bacterial strains 
Forty-six P aeruginosa strains were isolated at the Voula 
General Hospital over the period from 21 February 
1995 to 26 March 1996. They were identified by 
standard microbiological methods (including tests for 
cytochrome oxidase, arginine dihydrolase, gelatinase, 
and growth at 42°C) and their identification was 
confirmed by the API20 NE System (Bio Merieux). 
Antibiotic susceptibility testing 
Antibiotic susceptibility to the antibiotics listed in 
Table 1 was determined by the disk diffusion method, 
according to published standards [21]. 
Serotyping 
Serotyping was performed by agglutination on slides, as 
previously described [22], using commercially obtained 
sera (Difco). 
Bacteriocin typing 
Bacteriocin typing was performed essentially according 
to Fyfe et a1 [23], as previously described [24]. 
Pulsed-field gel electrophoresis of macrorestricted 
genomic DNA 
A modification of three previously published protocols 
was followed [13,14,25]. Briefly, 600 pL of an over- 
night bacterial culture in nutrient broth was harvested 
at  4°C and washed twice in cold phosphate-buffered 
saline (PBS) (137 mM NaCI, 2.7 mM KC1, 4.3 mM 
Na2HP04, 1.4 mM KH2P04, pH 7.5). The cells were 
resuspended in 300 pL of PBS, to which 20 pL of 
lysozyme (25 mg/mL) and 300 pL of 2% low-melting- 
point agarose in PBS was added. After thorough 
mixing, two 100-yL aliquots for each strain were 
dispensed in plastic molds (BioRad). After the plugs 
had set, they were incubated in 500 pL of PBS at 37OC 
for 1 h. They were rinsed with 1 mL of 0.5 M EDTA, 
p H  9.0, and then incubated in 500pL of 
filter-sterilized ES buffer (0.5 M EDTA, pH 9.0, 1% 
N-lauroylsarcosine) containing 5 pg of proteinase K, 
overnight at 55 "C. They were washed 6 X 30 min with 
850 pL of TE  buffer (10 mM Tris-HC1, 1 mM EDTA, 
pH 7.6), and one plug for each strain was incubated 
with 40 u of XbaI (New England Biolabs) in a total 
reaction volume of 250 pL, overnight at 37°C. After 
digestion, the plugs were equilibrated in x 0.5 TBE 
buffer (45 mM Tris-borate, 1 mM EDTA) and electro- 
phoresed through a 1% agarose gel in x0.5 TBE, which 
had been pre-run for 1 h, using a CHEF DRIII 
apparatus (BioRad). The gel was run at 14"C, 6 V/cm 
and 120" switch angle for 18 h, using the linear switch 
time ramps indicated in each figure legend. It was then 
stained in 0.5 pg/mL ethidium bromide and photo- 
graphed (Polaroid) under W illumination. Lambda 
phage DNA concatamers (New England Biolabs) were 
used as DNA size markers. The isolates' chromosomal 
fingerprints were compared by eye and assigned to 
PFGE types and subtypes, according to published 
guidelines [26,27]. 
Lipopolysaccharide electrophoresis 
Cell wall lipopolysaccharides were prepared and 
separated by sodium dodecylsulfate polyacrylamide 
gel electrophoresis (SDS-PAGE), followed by silver 
staining, using essentially the Aucken and Pitt [28] 
modification of the proteinase K method of Hitchcock 
and Brown [29], as already described [30]. 
RESULTS 
Over the last 9 months of 1995 and during 1996, the 
frequencies of l? aeruginosa isolation in the Voula 
General Hospital were 14% and 13.7%, respectively, 
making this organism the second most frequently 
isolated after Escherichia coli (19.7% and 18.9%). One- 
fifth to 27% of all P aeruginosa strains isolated came 
from the ICU, where this organism represented 18.9% 
and 16.9% of total isolates over the same periods, being 
second only to Acinetobacter baumannii (19.8%) in 1995 
or Staphylococcus aureus (28%) in 1996. During the 
period from 27 August 1995 to 10 November 1995, 
13 I? aeruginosa strains that were resistant to all anti- 
pseudomonal antibiotics were isolated from a total of 
49 specimens (47 from the trachea, one from bedsores, 
and one from urine) originating from 10 patients in 
the Voula General Hospital, Athens, Greece. Twelve 
isolates were from the ICU and one was from a patient 
of the general surgery B ward, who had been moved 
there from the ICU a month earlier. The ICU patients 
had a wide variety of clinical conditions, and four of 
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- 0 1  A701 27/08/95 ICU t P Z I C X A T F 11 10/a A1 
02 A687 21/08/95 ICU t P Z ( 1 ) C  X A T  F 11 1 O/a A2 
02 A817 22/09/95 ICU t P Z I C X A T F 11 10/a A3 
03 GS-B 
A 732 04/09/95 ICU t P Z I C X A T F 11 10/a A4 
03 A935 17/10/95 S-B t P Z ( 1 ) C  X A T  F 1 1  10/a A4 
05 n 7 1 4  15/09/95 ICU bs P Z I C X A T F 1 1  10/a A1 
04 A791 18/09/95 ICU t P Z I C X A T F 11 10/a A4 
08 A857 02/10/95 ICU t P Z I C X A T F 11 10/a A1 
07 A981 26/10/95 ICU t P Z I C X A T F I I  10/a A1 
09 A987 26/10/95 ICU t P Z I C X  T F PA 10/a A2 
09 A15 03/11/95 ICU t P Z I C X A T F I1 10/a A3 
06 A992 30/10/95 ICU t P Z  X A T F 1 1  10/a A5 
06 A41 10/11/95 ICU t P Z I C X A T F 1 1  10/a A5 
10 A29 07/11/95 ICU t P Z I C X A T F 1 1  1 O/a A5 
08 A823 25/09/95 ICU t 6 99/p B 
- 10 A40 10/11/95 ICU t P Z ( 1 ) C  X A T  F 11 10/a A5 
Table 1 List of strains and summary of results 
Resistance phenotype 
Patient Isolate Isolation Specimen Sero- Bacteriocin PFGE 
No. No. date Ward ofisolation P Z I C X A T F type type type 
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isolate A823 was distinct by all three methods (Table 1): 
it was of serogroup 0 :6 ,  pyocin type 99/p and PFGE 
type B. All other isolates were grouped together, by 
serogroup, 0:11, pyocin type, 10/a, and PFGE type, A 
(Table 1). The exception was the amikacin-sensitive 
isolate A987, which differed from the rest only with 
respect to its 0 serogroup: it was polyagglutinable, 
rather than 0: 11. This difference was explained when 
cell wall lipopolysaccharide SDS-PAGE was performed 
(Figure 2). Isolate A987 lacked the polysaccharide 
‘ladder’, formed by the 0 side-chains, displaying instead 
a pattern characteristic of ‘rough’ strains (Figure 2, lane 
3). In contrast, 0:11 isolates, though they differed in 
their antibiotypes and/or PFGE subtypes, displayed 
indistinguishable and extensive polysaccharide ‘ladders’ 
(Figure 2, lanes 1, 2 and 4). DNA fingerprinting by 
PFGE allowed further distinctions to be made among 
isolates belonging to type A, since this could be divided 
further into subtypes, A1 to A5, differing between 
them by six, or fewer, bands (Figure 1). For example, 
A2 differed from A1 in the region between the 97-kb 
and 48.5-kb markers (Figure lb, compare lane 5 to lane 
4), while A4 had additional differences in the region 
below the 48.5-kb band (Figure lb, compare lane 7 to 
lane 3). A3 yielded an additional fragment below the 
194-kb marker (Figure la, compare lane 5 to lane 3), 
while A5 displayed a closely spaced doublet in the 
194-kb position (Figure l a ,  compare lane 12 to lane 13). 
Figure 1 Pulsed-field gel electrophoresis patterns of the 
ICU epidemic isolates. (a) Linear ramp of switch times 0.5 s 
to 20 s, to resolve the higher-molecular-weight regions of 
the gel. The sizes, in kb, of h phage DNA concatamers are 
inmcated to the left of the gel. (b) Linear ramp of switch 
times 0.5 s to 10 s, to resolve the lower-molecular-weight 
regions of the gel. The sizes, in kb, of h phage DNA 
concatamers are indicated to the left of the gel. 
them died during or within 2 months of the epidemic. 
During the same period, only three more I? aeruginosa 
strains, all from the ICU, were isolated: A823 was 
sensitive to all antibiotics, A987 was only sensitive to 
amikacin, and A992 was sensitive only to imipenem and 
ceftazidime. The possibility that a single strain might be 
causing an outbreak in the ICU was investigated by 
digested with X6aI (Figure 1). As expected, the sensitive 
Figure 2 Silver-stained SDS-PAGE of cell wall 
lipopolysaccharides from representative PFGE type A 
strains. PA=polyagglutinable. 
serotyping7 pyocin typing and PFGE Of genomic DNA 
T a s s i o s  e t  a l :  M u l t i r e s i s t a n t  P s e u d o m o n a s  a e r u g i n o s a  0:ll o u t b r e a k  625 
Since clone A was not restricted to the ICU, 
but had also appeared in the surgery ward, its disper- 
sion throughout the hospital was examined. In total, 
therefore, 46 I? aeruginosa strains from different wards, 
from periods both before, during and after the ICU 
outbreak, and representing 22% of all l? aevuginosa 
strains isolated over the study period, were typed by 
the same methods. All isolates were nosocomial, using 
the post-48 h definition, with the exception of 0800, 
which was isolated the next day after patient admission. 
It was indeed found that clone A was present right 
from the beginning of the study period, occurring 
in nine out of 10 wards from which P aeruginosa had 
been isolated, and in four out of 10 different kinds of 
specimen (Table 1). However, of the 32 strains that 
belonged to type A, only 11 that were isolated in the 
ICU during the August-November 1995 outbreak 
were resistant to both ceftazidime and imipenem; 
in other wards, or the ICU at times before or after 
the outbreak, A strains were sensitive to one or both of 
these antibiotics (Table 1). Conversely, of the 13 strains 
that were ceftazidime and imipenem resistant, 11 
belonged to type A. The other two were strain 0 8 8 6 ,  
of PFGE type G, isolated from a patient on his second 
day after transfer from a different hospital, and no. 63, 
the third strain isolated belonging to type I: this clone 
had been followed as it was gradually acquiring resist- 
ance traits (Table 1). 
Overall, 17 antibiotypes (considering intermediate 
resistance as a distinct phenotype), seven 0 serogroups, 
12 pyocin types, and 12 PFGE types plus six subtypes 
(Figure 3) were observed among the 46 strains. 
Serogroup 0:ll was prevalent, including 32 of the 
46 isolates (70%), with 31 of these belonging to PFGE 
type A, and one to type J. Serogroup 0 : 6  was repre- 
sented by seven strains (15%), only two of which 
were multiresistant. Only two strains (4%), both multi- 
resistant, belonged to serogroup 0: 12. 
Resistance rates to the antibiotics tested ranged 
from 74% to 83%, with the exception of imipenem 
and ceftazidime, for which they were 37% and 5096, 
respectively. However, unlike resistance rates of all 
other antibiotics, which did not vary greatly among 
different hospital wards, imipenem and ceftazidime 
resistance was much more noted in the ICU (70% 
and 65%, respectively) than elsewhere (4% and 3.5%). 
In other words, 94%) of all imipenem-resistant and 65% 
of ceftazidime-resistant isolates occurred within the 
ICU. The resistance phenotypes of all isolates studied 
are shown in Table 1. In addition to the antibiotics 
indicated, resistance to timentin (TIM) followed that to 
aztreonam (AZT), with the exception of isolates 0800 
(TIMK/AZT1), no. 63 (TIMR/AZTS), and A687b 
(TIMS/AZTK). Gentamicin (GEN) resistance followed 
Figure 3 Strains representing all PFGE types observed 
throughout the hospital during the study period. Linear 
ramp of switch times 0.5 s to 20 s. The sizes, in kb, of h 
phage DNA concatamers are indicated to the left of the gel. 
that to amikacin (AMK), with the exception of isolate 
A987 (GEN1/AMKs), netilmicin followed tobramycin, 
while pefloxacin, ofloxacin and norfloxacin followed 
ciprofloxacin, with the exception of isolates A687b, 
which was sensitive to the latter two only, and isolate 
0817,  which was sensitive to ciprofloxacin only. 
With respect to DNA fingerprinting by PFGE, 32 
of 46 (70%) isolates belonged to type A; within this 
type, subtypes A1 (47%) and A5 (25%) were dominant. 
All A isolates were multiresistant, serogroup 0:11, 
bacteriocin type 10/a, with the exception of A987, 
which was polyagglutinable and pyocin type 10/a. 
Types B to L were each represented by only one strain, 
with the exception of I ,  grouping four isolates (Y'%). 
Types A, D, G, I ,  K and L (six types, 38 strains) 
corresponded to multiresistant isolates, contrary to 
types B, C, E, F, H and J, which grouped more sensitive 
strains (six types, six strains). 
PFGE type A was dominant (74% of isolates) in 
the ICU, followed by I (23%), while B and D were 
each represented by one strain. The greatest genotypic 
variety was obtained in the orthopedic E ward (PFGE 
types A (two strains), C (one strain), E (one strain), H 
(one strain), J (one strain)). 
The majority of strains were isolated from the 
trachea (SO%), followed by urine (33%) and various 
wound exudates (13%). In all cases, PFGE type A was 
prevalent, representing 78%, 80% and 50% of isolates 
from the above specimens, respectively. 
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DISCUSSION 
A nosocomial multiresistant I? aeruginosa 0:11 strain 
was identified, which not only caused the ICU epidemic 
but was also widespread in the rest of the hospital. 
The fact that a second outbreak was not observed 
was attributed to the reinforcement of strict hygiene 
measures taken to exclude transmission via hospital 
personnel, and the thorough decontamination of the 
ICU ward and all equipment used. 
Typing by PFGE afforded the highest discrimina- 
tion among strains. Although it would appear that 
antibiotic susceptibility was equally discriminatory, 
having yielded the same number of types, 17, it was 
clearly misleading as to strain identity, since, for 
example, it could not discriminate between A963 and 
A204, which differed by all other methods. Pyocin 
typing (12 types) was almost twice as efficient as sero- 
typing (seven types) in distinguishing between strains 
and equal to DNA fingerprinting by PFGE (12 types). 
However, the latter method could divide the dominant 
type further into six subtypes, thus significantly in- 
creasing discriminatory ability. The subtle variations in 
the genomic macrorestriction patterns of different A 
subtypes did not correlate with phenotypic differences 
and were such as can be expected from closely related 
I? aeruginosa strains, including consecutive isolates from 
the same patient [14, 311. 
Furthermore, and most importantly for the epi- 
demiologic surveillance of antibiotic resistance, only 
PFGE allowed us to follow a specific clone, I, as it was 
gradually evolving towards a more resistant phenotype 
(Table 1). This clone was represented by four geno- 
typically indistinguishable isolates, A323, 6393, no. 
63 and A687b, all from the ICU and from different 
patients. The first two isolates were phenotypically 
identical, except with respect to their susceptibility to 
piperacillin. However, when the next strain, no. 63, was 
isolated 5 weeks later, the pyocin type had changed 
from 1 l / y  to 6/e, as was the case for the last isolate of 
the same clone, A687b. This change was concomitant 
with a change in antibiotype, as the latter strains were 
resistant to other p-lactams and to quinolones, contrary 
to the former two. It would appear that no. 63 and 
A687b had both diverged independently from 6393, 
rather than being sequential stages of a single evolving 
strain, since no. 63 was resistant to all quinolones and 
cephalosporins, contrary to the later isolate, A687b. 
PFGE revealed a greater genetic homogeneity 
among multiresistant isolates, compared with the rest. 
This is to be expected in a hospital environment, where 
the pressure of antibiotic usage favors the selection 
and clonal expansion of resistant strains. Indeed, multi- 
resistant clone A was endemic in the hospital: it had 
been present before the ICU outbreak and persisted 
after it. An A1 strain even managed to replace, within 
a week, the sensitive strain B carried by patient 08. 
It was interesting to note that neither clone I nor 
the more widespread clone A belonged to the 'typical' 
serogroup for multiresistant strains, 0: 12, which has 
been shown to be widespread in Greece [19], as in 
Europe [20]. In fact, there were only two 0 :12  strains 
isolated in our hospital during the study period, and 
these were indeed multiresistant. A Greek multicenter 
study, however, has shown that the clinically prevalent 
serogroups are precisely 0:l l  and 0:12, both largely 
associated with multiresistant phenotypes (unpublished 
results). In the past, serogroup 0:11 had been described 
as one of the most common, both from environmental 
water sources [32-341 and in hospital epidemics [35-371, 
across Europe and in the USA, but, in general, had not 
been associated with high resistance rates. Specifically, 
15 years ago in Greece, 0:11 had been described as 
a generally antibiotic-sensitive serogroup, unlike 0:12 
[38]. However, there have been recent reports of 0:11 
strains exhibiting resistance to aminoglycosides [39] or 
aminoglycosides and quinolones [40], but not to p- 
lactams, as in the present study. Indeed, in our hospital, 
resistance to p-lactams was always crossed to both 
aminoglycosides and quinolones, with the exception of 
the PFGE type I isolates, and the polyagglutinable strain 
A987. Finally, whereas endemic clone A was generally 
sensitive to ceftazidime and imipenem, within the ICU 
it developed resistance to these antibiotics, presumably 
because of their long-term use in that environment. 
Since all except one of the ICU outbreak isolates 
came from the trachea, a common site of colonization, 
it is impossible to tell whether clone A was causing an 
infection in ICU patients already suffering from serious 
underlying conditions. However, it has been proposed 
recently [41] that carrier status should be seriously 
taken into account in a definition and surveillance of 
nosocomial infections; at any rate, A strains were clearly 
infectious in wards outside the ICU. Moreover, the 
evolution of a strain, belonging to a serogroup pre- 
viously considered susceptible, to a totally resistant 
state, including resistance to imipenem, is cause for 
alarm. Development of resistance during antibiotic 
treatment, especially within an ICU and for I? aeruginosa 
[42], is, of course, a well-known phenomenon, which 
has been described for various antibiotics [43], in- 
cluding 0-lactams [44-461. Such an evolution was 
traced most strikingly with strains A323, A393, no. 63 
and A687b. These genotypically indistinguishable 
(PFGE type I) isolates were all phenotypically 0 : 6 ,  one 
of the most common clinically encountered serogroups 
[35,38,47]. However, in the space of 2 months, clone 
I had developed from resistance to only one antibiotic 
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to multi-resistance. Parallel with its acquisition of 
resistance traits, its pyocin type changed from l l / y  to 
6/e. Phenotypic changes unaccompanied by a change 
in genotype are a frequent observation in strains which 
persist in the human host, such as those infecting cystic 
fibrosis patients [48,49]; long-term tracheal coloniza- 
tion in an ICU setting can be thought of as a similar 
mode of persistence. Another similarity between the 
two conditions is illustrated by isolate A987 of our 
study. This converted to a polyagglutinable serogroup, 
by losing its polysaccharide side-chains, while remain- 
ing genotypically indistinguishable from other clone 
A strains. Conversion to polyagglutinability is wide- 
spread among cystic fibrosis I? aeruginosa strains, and is 
attributed to their long-term persistence in the lungs 
[4], though loss of lipopolysaccharide side-chains has 
also been noted in other chronic colonization contexts 
In conclusion, we have characterized a multi- 
resistant 0: 11 strain, distinct from the dominant 
European multiresistant 0: 12 clone, by serotyping, 
bacteriocin typing and PFGE. The last method also 
allowed us to trace an 0 : 6  clone as it was gradually 
becoming more resistant, and underwent a bacteriocin- 
type conversion, within the ICU. This study therefore 
presented two striking examples of the power and 
usefulness of PFGE in a nosocomial environment, not 
only in the investigation of outbreaks, but also in the 
monitoring of strain evolution and dissemination. 
1501. 
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